Correlation Between Pulmatrix and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Pulmatrix and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Cyclacel Pharmaceuticals.
Diversification Opportunities for Pulmatrix and Cyclacel Pharmaceuticals
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pulmatrix and Cyclacel is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Pulmatrix i.e., Pulmatrix and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pulmatrix and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days Pulmatrix is expected to generate 1.34 times more return on investment than Cyclacel Pharmaceuticals. However, Pulmatrix is 1.34 times more volatile than Cyclacel Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 196.00 in Pulmatrix on September 1, 2024 and sell it today you would earn a total of 468.00 from holding Pulmatrix or generate 238.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pulmatrix vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| Pulmatrix |
| Cyclacel Pharmaceuticals |
Pulmatrix and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pulmatrix and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Pulmatrix and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |